Maidenhead, United Kingdom

Bryan John Smith

This inventor holds 1 USPTO granted patent. Top assignee: Celltech Therapeutics Limited. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bryan John Smith. Retrieved from https://idiyas.com/inventor/bryan-john-smith-plvpkpdt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Bryan John Smith

Introduction

Bryan John Smith is a notable inventor based in Maidenhead, GB. He has made significant contributions to the field of biotechnology, particularly in the development of hybrid proteins. His work has implications for both therapy and diagnosis in medicine.

Latest Patents

Bryan John Smith holds a patent for "Antibody-serum protein hybrids." This patent describes hybrid proteins that consist of one or more antigen-binding antibody fragments covalently linked to serum carrier proteins. These hybrid proteins are designed to bind antigens and possess a long half-life in vivo, making them valuable for medical applications.

Career Highlights

Bryan is associated with Celltech Therapeutics Limited, a company known for its innovative approaches in biotechnology. His role at the company has allowed him to focus on the development of advanced therapeutic solutions.

Collaborations

Due to space constraints, the collaborations section will be omitted.

Conclusion

Bryan John Smith's work in developing antibody-serum protein hybrids showcases his innovative spirit and commitment to advancing medical science. His contributions are paving the way for new therapeutic and diagnostic possibilities.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…